Abstract
While cholesterol is essential for human life, a high level of cholesterol is closely linked with the risk of cardiovascular diseases. Genome-wide association studies (GWASs) have been successful to identify genetic variants associated with cholesterol, which have been conducted mostly in white European populations. Consequently, it remains mostly unknown how genetic effects on cholesterol vary across ancestries. Here, we estimate cross-ancestry genetic correlation to address questions on how genetic effects are shared across ancestries for cholesterol. We find significant genetic heterogeneity between ancestries for total- and LDL-cholesterol. Furthermore, we show that single nucleotide polymorphisms (SNPs), which have concordant effects across ancestries for cholesterol, are more frequently found in the regulatory region, compared to the other genomic regions. Indeed, the positive genetic covariance between ancestries is mostly driven by the effects of the concordant SNPs, whereas the genetic heterogeneity is attributed to the discordant SNPs. We also show that the predictive ability of the concordant SNPs is significantly higher than the discordant SNPs in the cross-ancestry polygenic prediction. The list of concordant SNPs for cholesterol is available in GWAS Catalog (https://www.ebi.ac.uk/gwas/; details are in web resources section). These findings have relevance for the understanding of shared genetic architecture across ancestries, contributing to the development of clinical strategies for polygenic prediction of cholesterol in cross-ancestral settings
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research is supported by the Australian Research Council (DP190100766). We thank the staff and participants of the UK Biobank and Biobank Japan for their important contributions. Our reference number approved by UK Biobank is 14575. The analyses were performed using computational resources provided by the Australian Government through Gadi under the National Computational Merit Allocation Scheme (NCMAS), and HPCs (Statgen server) managed by UniSA IT.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The genotype and phenotype data of the UK Biobank can be accessed through procedures described on its webpage (https://www.ukbiobank.ac.uk/) and summary statistics of BMI and total-, LDL- and HDL-cholesterol from Biobank Japan (BBJ) can be obtained from its website (http://jenger.riken.jp/en/result) MTG2, https://sites.google.com/site/honglee0707/mtg2 PLINK2 version can be downloaded from https://www.cog-genomics.org/plink/ r2redux R-package (https://github.com/mommy003/r2redux from GitHub or from CRAN) The GWAS summary statistics dataset that is generated in this current study and supports the findings have been deposited in the NHGRI-EBI GWAS catalogue with the accession codes GCST90244051, GCST90244052, GCST90244053, GCST90244054, GCST90244055 and GCST90244056; (https://www.ebi.ac.uk/gwas/). GWAS for all SNPs and concordant SNPs for total-, HDL- and LDL-cholesterol can be accessed in following links GWAS of total cholesterol (all SNP) (https://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90244001-GCST90245000/GCST90244051/) GWAS of total cholesterol (concordant SNP) (https://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90244001-GCST90245000/GCST90244052/) GWAS of HDL-cholesterol (all SNP) (https://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90244001-GCST90245000/GCST90244053/) GWAS for HDL-cholesterol (concordant SNP) (https://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90244001-GCST90245000/GCST90244054/) GWAS for LDL-cholesterol (all SNP) (https://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90244001-GCST90245000/GCST90244055/) GWAS for LDL-cholesterol (concordant SNP) (https://ftp.ebi.ac.uk/pub/databases/gwas/summary_statistics/GCST90244001-GCST90245000/GCST90244056/)
